[Clinical trial of LA-1225 shampoo and lotion in seborrheic dermatitis and of LA-1275 shampoo and lotion in pityriasis sicca].
D000293:Adolescent; D000328:Adult; D000368:Aged; D003545:Cysteine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D012628:Dermatitis, Seborrheic / Q000628:therapy*; D004338:Drug Combinations / Q000008:administration & dosage; D005260:Female; D006203:Hair Preparations / Q000008:administration & dosage*; D006801:Humans; D008239:Lysine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D008297:Male; D008875:Middle Aged; D010915:Pityriasis / Q000628:therapy*; D000644:Quaternary Ammonium Compounds / Q000008:administration & dosage*; D012459:Salicylates / Q000008:administration & dosage*; D014476:Undecylenic Acids / Q000008:administration & dosage*; D014508:Urea / Q000008:administration & dosage*
D004338:Drug Combinations; D006203:Hair Preparations; D000644:Quaternary Ammonium Compounds; D012459:Salicylates; D014476:Undecylenic Acids; C033723:LA 1225; C033724:LA-1275; D014508:Urea; D008239:Lysine; D003545:Cysteine
Ensayo clínico de LA-1225 champú y loción en dermatitis seborreica t de LA-1275 champú loción en pitiriasis seca.